Biggest News Aggregation in the World
📰 Linkedin News

Page 23 - Linkedin News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Linkedin. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

U.S. Food and Drug Administration Approves Augtyrotm (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), for the Treatment of Patients with NTRK-Positive Locally Advanced or Metastatic Solid Tumors

Bristol Myers Squibb today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Augtyrotm (repotrectinib) for the treatment of adult and pediatric patients 12 years of age and older with solid tumors that...
Bristol Myers Squibb Nick Botwood Alexander Drilon Susan Spinosa Drug Administration Approves Augtyrotm National Cancer Institute

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science